KELA_REIMBURSEMENT_202

K11_REIMB_202

No definition available.

Endpoint definition

FinnGen phenotype data

414262 individuals

diagram downward connector

Apply sex-specific rule None

414262

diagram downward connector

Check conditions None

414262

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes 202

1 out of 7 registries used, show all original rules.

22498

diagram downward connector

Check minimum number of events None

22498

diagram downward connector

Include endpoints None

22498

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

20730

diagram downward connector
K11_REIMB_202

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 20730 13477 7253
Unadjusted prevalence (%) 5.50 6.39 4.36
Mean age at first event (years) 46.49 45.28 48.74

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.88 [1.63, 2.18] 8.7e-18 2103
15 years 0.01 1.38 [1.22, 1.55] 1.7e-7 980
5 years 0.00 1.89 [1.66, 2.15] 2.0e-22 412
1 year 0.00 2.38 [1.90, 2.98] 5.7e-14 95

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: K11_REIMB_202 – KELA_REIMBURSEMENT_202
GWS hits: 36

Survival analyses between endpoints

Plot

before KELA_REIMBURSEMENT_202
after KELA_REIMBURSEMENT_202

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after KELA_REIMBURSEMENT_202

Endpoint not on priority list, no data to show.